LSL Pharma Quote - LSL | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
Canada
TSXV
LSL Pharma Group Inc (LSL) Share Price

LSL Pharma Group Inc (LSL)

0.425

-0.005

(-1.16%)

Closed November 27 3:00PM

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

0.425

Bid

0.425

Ask

0.43

Volume

14,800

0.425 Day's Range 0.43

0.35 52 Week Range 0.55

Market Cap

Previous Close

0.43

Open

0.425

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

46,232

Shares Outstanding

82,435,000

Dividend Yield

-

PE Ratio

-4.09

Earnings Per Share (EPS)

-0.1

Revenue

10.03M

Net Profit

-8.47M

Sector

Pharmaceutical Preparations

Industry

Blank Checks

Website

www.groupelslpharma.com

Headquarters

Quebec City, Quebec, Can

Founded

2011

LSL Pharma Group Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker LSL. The last closing price for LSL Pharma was $0.43. Over the last year, LSL Pharma shares have traded in a share price range of $ 0.35 to $ 0.55.

LSL Pharma currently has 82,435,000 shares outstanding. The market capitalization of LSL Pharma is $35.45 million. LSL Pharma has a price to earnings ratio (PE ratio) of -4.09.

LSL PHARMA GROUP ANNOUNCES STRONG FISCAL Q3-24 RESULTS AND $2.4 MILLION DEBT FINANCINGS TO SUPPORT ITS GROWTH INITIATIVES

LSL PHARMA GROUP ANNOUNCES STRONG FISCAL Q3-24 RESULTS AND $2.4 MILLION DEBT FINANCINGS TO SUPPORT ITS GROWTH INITIATIVES Canada NewsWire BOUCHERVILLE, QC, Nov. 25, 2024 Revenues of $4.0 million...

LSL PHARMA GROUP ANNONCES $1.4 MILLION OF NEW ORDERS FROM INTERNATIONAL CLIENTS AND COMPLETION OF STERI-MED PHARMA'S PHASE 1 PRODUCTION SCALE UP

LSL PHARMA GROUP ANNONCES $1.4 MILLION OF NEW ORDERS FROM INTERNATIONAL CLIENTS AND COMPLETION OF STERI-MED PHARMA'S PHASE 1 PRODUCTION SCALE UP Canada NewsWire BOUCHERVILLE, QC, Nov. 6, 2024...

LSL PHARMA GROUP ANNOUNCES THE FIRST INTEREST PAYMENT ON THE CONVERTIBLE DEBENTURES LISTED AS LSL.DB

LSL PHARMA GROUP ANNOUNCES THE FIRST INTEREST PAYMENT ON THE CONVERTIBLE DEBENTURES LISTED AS LSL.DB Canada NewsWire BOUCHERVILLE, QC, Oct. 24, 2024 BOUCHERVILLE, QC, Oct. 24, 2024 /CNW/ - LSL...

LSL PHARMA GROUP ANNOUNCES CHANGE OF AUDITORS AND GRANT OF OPTIONS

LSL PHARMA GROUP ANNOUNCES CHANGE OF AUDITORS AND GRANT OF OPTIONS Canada NewsWire BOUCHERVILLE, QC, Sept. 26, 2024 BOUCHERVILLE, QC, Sept. 26, 2024 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL...

LSL PHARMA GROUP REPORTS RECORD REVENUES FOR THE SECOND QUARTER 2024

LSL PHARMA GROUP REPORTS RECORD REVENUES FOR THE SECOND QUARTER 2024 Canada NewsWire BOUCHERVILLE, QC, Aug. 26, 2024 Record Revenues of $4.2 million in Q2-24 up 106% over Q2-23Operating profits...

LSL Pharma Group Announces Closing of Second and Final Tranche of Private Placement and Closing of Units for Debt

BOUCHERVILLE, Quebec, July 15, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a Canadian integrated pharmaceutical company, is pleased to...

LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders

BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased...

LSL Pharma Group Secures $1.5 Million as the First Closing of Its Non-Brokered Private Placement

BOUCHERVILLE, Quebec, June 27, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, announced...

LSL Pharma Group Completes the Acquisition of Virage Santé

BOUCHERVILLE, Québec, June 18, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) ("the Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, is pleased to...

LSL Pharma Group Announces Engagement of Red Cloud Securities

BOUCHERVILLE, Quebec, June 11, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a Canadian integrated pharmaceutical company, announces that...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.03	-6.59340659341	0.455	0.455	0.385	62121	0.41013863	CS
4	0.015	3.65853658537	0.41	0.49	0.385	52796	0.44406253	CS
12	-0.065	-13.2653061224	0.49	0.5	0.37	46232	0.44585777	CS
26	-0.075	-15	0.5	0.53	0.37	30339	0.45892854	CS
52	0.005	1.19047619048	0.42	0.55	0.35	30216	0.44455177	CS
156	-0.275	-39.2857142857	0.7	1	0.35	25782	0.46540517	CS
260	-0.275	-39.2857142857	0.7	1	0.35	25782	0.46540517	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NHT.UNexpoint Hospitality Trust	US$ 0.30 (1,900.00%)	4k
SCANLiberty Defense Holdiings LTD	$ 0.46 (820.00%)	19.72k
HPLHorizon Petroleum Ltd	0.17 (325.00%)	10k
CPLCopper Lake Resources Ltd	$ 0.01 (100.00%)	20k
KIBKiboko Gold Inc	$ 0.02 (100.00%)	495k
RAC.PRiverwalk Acquisition Corp	$ 0.005 (-90.00%)	15k
ACAP.PAtlas One Capital Corporation	$ 0.005 (-66.67%)	8k
AMG.PAMG Acquisition Corp	$ 0.02 (-60.00%)	20k
EGTEguana Technologies Inc	$ 0.005 (-50.00%)	3k
DMDataMetrex AI Limited	$ 0.005 (-50.00%)	2.41M
BARUBaru Gold Corp	$ 0.045 (12.50%)	2.8M
MATEBlockmate Ventures Inc	$ 0.125 (-7.41%)	2.49M
DMDataMetrex AI Limited	$ 0.005 (-50.00%)	2.41M
FANFirst Atlantic Nickel Corp	$ 0.25 (28.21%)	2.27M
RHCRoyal Helium Ltd	$ 0.045 (28.57%)	2.05M

muee88

muee88 9 minutes ago

The procedural history here was a bit odd. The court essentially allowed the plaintiff to provisionally amend their complaint along with motioning the court to formally allow them to amend. The court then took 7 months to review the proposed changes and grant the plaintiffs motion to amend. Plaintif

devil dog 96

devil dog 96 12 minutes ago

Do you really think they are scamming us 90 cents at a time? 😃 LMAO

" Another 90 cent trade!! "

I have been telling you it's not easy getting shares on the BID. Everyone is holding this one tight for management to start their marketing campaign. All you will get

CrashOverride

CrashOverride 12 minutes ago

Extraordinary claims require extraordinary evidence as well as rigorous analysis!

CrashOverride

CrashOverride 13 minutes ago

CrashOverride

CrashOverride 15 minutes ago

Hilarious

https://x.com/hoffmann6383/status/1861618491058491410?t=Vz6DfxDX7y4LoRsdLbcyOQ&s=19

BakedLangostino

BakedLangostino 20 minutes ago

There is definitely going to be competition from all angles. My hope is that the Sigmar1 moat is fairly deep and will prevent enough direct competition until something better comes along, hopefully A371.

Ozempic may work well but if it restricts appetite in non-obese populations, I c

Batman412

Batman412 21 minutes ago

It's a scummy company on the verge of bankruptcy

Batman412

Batman412 22 minutes ago

They posted a pr saying Ai callers is division of bot makers before any share agreement or anything of the sort showing a connection

Bright Boy

Bright Boy 23 minutes ago

Without question, the best news I've heard in the 8 years I've been a shareholder in Northwest!!! Today, Judge Ho, Federal Judge in the Southern District of New York, allowed the Phunware case to survive the MTD and proceed to Discovery and Trial. This is the same district that the Northwest case i

Batman412

Batman412 23 minutes ago

We've seen this the last few weeks but it doesn't move it's gonna take more than a few million to move it

Viking61

Viking61 24 minutes ago

You’re absolutely right, Rick!!!!

BakedLangostino

BakedLangostino 30 minutes ago

Where did the Amazon rumor originate? Was that something that started on this forum or is there a transcript somewhere of Dr. Missling mentioning Amazon as a potential partner? Because the more I think about it, the more it makes sense.

1. It's would be a big splash for Amazon's fled

E A

E A 32 minutes ago

546 days since Timothy Holly took over as CEO. Still in expert market.

They’re trying to save our investments, I don’t see any red flags there

I SEE a 5.2 billion valuation…

There’s potential here. You haven’t done your hw

dinogreeves

dinogreeves 33 minutes ago

This is terrible

https://finance.yahoo.com/quote/PGHL/

dinogreeves

dinogreeves 34 minutes ago

Now look at this, now this what you call gamblers that will lose everything on nothing. Now, that is sad, truly sad. Only 13 million in revenues. 660,000 volume, where are the bag holders trapped from?

https://finance.yahoo.com/quote/PGHL/

https://finance.yahoo.com/

RickNagra

RickNagra 35 minutes ago

Wrong. Look again carefully. I recommend zooming in. It says com and not con.

BamaBreeze

BamaBreeze 39 minutes ago

The management would stand to make A lot of money. More than cheating shareholders out of theirs. That would be a major incentive I would think.

jondoeuk

jondoeuk 40 minutes ago

A post on LinkedIn (by Alex Shih-Min Huang who is VP, Head of Cell Therapy at BGNE): 'Though our very first experiment was initiated only 2.5 years ago amidst ongoing laboratory construction and pandemic, fast forward to this day, we have already 1) generated a proprietary, well-characterized GMP gr

gfp927z

gfp927z 40 minutes ago

Acurx - >>> MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000

Barron's

by Paul R. La Monica

Nov 22, 2024

https://www.barrons.com/articles/microstrategy-copycats-companies-buy-bitcoin-0032c5ff?siteid=yhoof2

dinogreeves

dinogreeves 41 minutes ago

Analyst are going to scratch their heads tomorrow if there is no press release based on all the notes fully paid off, upwards of 2 billion dollars, if the numbers were cooked and there was going to be fraud charges against the company, they would have taken the money and ran, but instead they paid i

Franklin Tem ICAV Frankl...

BlackRock Institutional ...

Nb Private Equity Partners

Matsa Resources

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions